Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00033462
Status:
COMPLETED
Last Update Posted:
2013-06-04
First Post:
2002-04-09
Brief Title:
Erlotinib in Treating Patients With Unresectable Liver Bile Duct or Gallbladder Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Adult Primary Cholangiocellular Carcinoma |
| Adult Primary Hepatocellular Carcinoma |
| Advanced Adult Primary Liver Cancer |
| Cholangiocarcinoma of the Extrahepatic Bile Duct |
| Cholangiocarcinoma of the Gallbladder |
| Localized Unresectable Adult Primary Liver Cancer |
| Recurrent Adult Primary Liver Cancer |
| Recurrent Extrahepatic Bile Duct Cancer |
| Recurrent Gallbladder Cancer |
| Unresectable Extrahepatic Bile Duct Cancer |
| Unresectable Gallbladder Cancer |
Keywords: